GH Guardant Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GH

Price (delayed)

$176.31

Market cap

$23.66B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.49

Enterprise value

$24.16B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 21
Highlights
The gross profit has grown by 48% YoY and by 10% from the previous quarter
Guardant Health's revenue has increased by 43% YoY and by 10% from the previous quarter
GH's equity is up by 27% YoY but it is down by 23% QoQ
Guardant Health's quick ratio has decreased by 16% from the previous quarter but it has increased by 7% YoY
The debt is up by 28% year-on-year
Guardant Health's net income has decreased by 10% YoY and by 4.7% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://guardanthealth.com
Peers: NEOG NTRA MYGN

Key stats

What are the main financial stats of GH

GH stock price

How has the Guardant Health stock price performed over time
Intraday
-0.48%
1 week
0.81%
1 month
3.29%
1 year
195.23%
YTD
72.62%
QTD
17.52%

Financial performance

How have Guardant Health's revenue and profit performed over time
Revenue
$1.18B
Gross profit
$769.16M
Operating income
-$470.26M
Net income
-$453.44M
Gross margin
65%
Net margin
-38.3%
The gross profit has grown by 48% YoY and by 10% from the previous quarter
Guardant Health's revenue has increased by 43% YoY and by 10% from the previous quarter
The company's operating margin rose by 29% YoY and by 4.1% QoQ
The net margin is up by 23% year-on-year and by 4.5% since the previous quarter

Price vs fundamentals

How does GH's price correlate with its fundamentals

Growth

What is Guardant Health's growth rate over time

Valuation

What is Guardant Health stock price valuation
P/E
N/A
P/B
N/A
P/S
19.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.42
The EPS has declined by 4.2% year-on-year and by 2.9% since the previous quarter
GH's equity is up by 27% YoY but it is down by 23% QoQ
The P/S is 83% above the 5-year quarterly average of 10.9 and 60% above the last 4 quarters average of 12.4
Guardant Health's revenue has increased by 43% YoY and by 10% from the previous quarter

Efficiency

How efficient is Guardant Health business performance
The return on sales is up by 23% year-on-year and by 4.5% since the previous quarter
GH's ROA is up by 12% year-on-year and by 3.8% since the previous quarter
Guardant Health's ROIC has increased by 8% YoY

Dividends

What is GH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GH.

Financial health

How did Guardant Health financials performed over time
Guardant Health's total assets is 10% less than its total liabilities
Guardant Health's total assets has increased by 44% YoY
The company's total liabilities rose by 30% YoY
GH's debt to equity has dropped by 75% year-on-year but it is up by 19% since the previous quarter
The debt is up by 28% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.